Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 5/2021

21.07.2021 | Case Report

Surgical resection of undifferentiated pleomorphic sarcoma (UPS) with jejunal perforation, a suspected case of metastasis of lung cancer

verfasst von: Ryotaro Eto, Isamu Hoshino, Nobuhiro Takiguchi, Toru Tonooka, Hisashi Gunji, Naoki Kuwayama, Itaru Sonoda, Makiko Itami, Masayuki Otsuka, Yoshihiro Nabeya

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Undifferentiated pleomorphic sarcoma (UPS) in the gastrointestinal tract is rare. According to the diagnostic criteria after the World Health Organization 2013 reclassification, there has been only one case of UPS with perforation of the gastrointestinal tract. A 71-year-old man who was undergoing outpatient chemotherapy at the department of respiratory medicine of our hospital for lung cancer and brain metastasis, was admitted to our hospital with sudden high fever and abdominal pain. A computed tomography scan showed free air in the abdominal cavity with thickening of part of the jejunal wall. We suspected jejunal metastasis of lung cancer and performed emergency surgery for acute peritonitis due to gastrointestinal perforation in the same area. A Bormann type 2 tumour was found in the jejunum with perforation. The histopathological diagnosis was UPS. Ten months have passed since the surgery, and there has been no recurrence of UPS and no significant change in lung cancer. Primary UPS of the gastrointestinal tract is rare, and cases with perforation are extremely rare. Currently, ten months have passed since the surgery, and no recurrence has been observed. We encountered a case of UPS in which it was difficult to distinguish metastasis from lung cancer to the jejunum, and the emergency surgery gave us the chance to confirm the definitive diagnosis and save the patient's life.
Literatur
1.
Zurück zum Zitat Fletcher CD, Unni K, Mertens F. World Health Organization Classification of Tumors: pathology and genetics of soft tissue and bone. 3rd ed. IARC Press; 2002. Fletcher CD, Unni K, Mertens F. World Health Organization Classification of Tumors: pathology and genetics of soft tissue and bone. 3rd ed. IARC Press; 2002.
2.
Zurück zum Zitat Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978;41:2250–66.CrossRef Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978;41:2250–66.CrossRef
3.
Zurück zum Zitat Fletcher C, Bridge JA, Hogendoorn PC, Mertens F. WHO classification of tumors of soft tissue and bone. 4th ed. IARC Press; 2013. Fletcher C, Bridge JA, Hogendoorn PC, Mertens F. WHO classification of tumors of soft tissue and bone. 4th ed. IARC Press; 2013.
4.
Zurück zum Zitat Morimoto M, Honjo S, Sakamoto T, et al. Laparoscopically-assisted repair of a small bowel perforation secondary to multiple metastases of undifferentiated pleomorphic sarcoma. Yonago Acta Med. 2020;63:122–6.CrossRef Morimoto M, Honjo S, Sakamoto T, et al. Laparoscopically-assisted repair of a small bowel perforation secondary to multiple metastases of undifferentiated pleomorphic sarcoma. Yonago Acta Med. 2020;63:122–6.CrossRef
5.
Zurück zum Zitat Saneesh PS, Verma P, Bano S, et al. CT of primary undifferentiated pleomorphic sarcoma of small intestine with distant metastases presenting with intussusception. Radiol Case Rep. 2020;15:44–8.CrossRef Saneesh PS, Verma P, Bano S, et al. CT of primary undifferentiated pleomorphic sarcoma of small intestine with distant metastases presenting with intussusception. Radiol Case Rep. 2020;15:44–8.CrossRef
6.
Zurück zum Zitat Fujisaki S, Takashina M, Sakurai K, et al. Long-term survival after resection for primary undifferentiated pleomorphic sarcoma of the jejunum with lymph node metastases: case report. J Cancer Ther. 2017;08:1079–85.CrossRef Fujisaki S, Takashina M, Sakurai K, et al. Long-term survival after resection for primary undifferentiated pleomorphic sarcoma of the jejunum with lymph node metastases: case report. J Cancer Ther. 2017;08:1079–85.CrossRef
7.
Zurück zum Zitat Oguri Y, Cho H, Oohinata R, et al. Aggressive undifferentiated pleomorphic sarcoma of the stomach involving long-term survival: a case report and literature review. Mol Clin Oncol. 2018;9:661–5.PubMedPubMedCentral Oguri Y, Cho H, Oohinata R, et al. Aggressive undifferentiated pleomorphic sarcoma of the stomach involving long-term survival: a case report and literature review. Mol Clin Oncol. 2018;9:661–5.PubMedPubMedCentral
8.
Zurück zum Zitat Kazama S, Gokita T, Takano M, et al. G-CSF-producing undifferentiated pleomorphic sarcoma adjacent to the ascending colon and in the right iliopsoas muscle: a case report and review of the literature. Intern Med. 2019;58:2783–9.CrossRef Kazama S, Gokita T, Takano M, et al. G-CSF-producing undifferentiated pleomorphic sarcoma adjacent to the ascending colon and in the right iliopsoas muscle: a case report and review of the literature. Intern Med. 2019;58:2783–9.CrossRef
9.
Zurück zum Zitat Ziwei X, Yueming S. Recurrent adult intraabdominal undifferentiated high-grade pleomorphic sarcoma infiltrated the descending colon: a case report and review of the literature. J Gastrointest Cancer. 2019;50:629–33.CrossRef Ziwei X, Yueming S. Recurrent adult intraabdominal undifferentiated high-grade pleomorphic sarcoma infiltrated the descending colon: a case report and review of the literature. J Gastrointest Cancer. 2019;50:629–33.CrossRef
10.
Zurück zum Zitat Lee JH, Kang DB, Park WC. Primary undifferentiated pleomorphic sarcoma of the colon mesentery. Ann Coloproctol. 2019;35:152–4.CrossRef Lee JH, Kang DB, Park WC. Primary undifferentiated pleomorphic sarcoma of the colon mesentery. Ann Coloproctol. 2019;35:152–4.CrossRef
11.
Zurück zum Zitat Diaz-Beveridge R, Melian M, Zac C, et al. Primary mesenteric undifferentiated pleomorphic sarcoma masquerading as a colon carcinoma: a case report and review of the literature. Case Rep Oncol Med. 2015;2015:532656.PubMedPubMedCentral Diaz-Beveridge R, Melian M, Zac C, et al. Primary mesenteric undifferentiated pleomorphic sarcoma masquerading as a colon carcinoma: a case report and review of the literature. Case Rep Oncol Med. 2015;2015:532656.PubMedPubMedCentral
12.
Zurück zum Zitat Plestina S, Librenjak N, Marusic A, et al. An extremely rare primary sarcoma of the lung with peritoneal and small bowel metastases: a case report. World J Surg Oncol. 2019;17:147.CrossRef Plestina S, Librenjak N, Marusic A, et al. An extremely rare primary sarcoma of the lung with peritoneal and small bowel metastases: a case report. World J Surg Oncol. 2019;17:147.CrossRef
13.
Zurück zum Zitat Goldblum JR. An approach to pleomorphic sarcomas: can we subclassify, and does it matter? Mod Pathol. 2014;27(Suppl 1):S39-46.CrossRef Goldblum JR. An approach to pleomorphic sarcomas: can we subclassify, and does it matter? Mod Pathol. 2014;27(Suppl 1):S39-46.CrossRef
14.
Zurück zum Zitat Matushansky I, Charytonowicz E, Mills J, et al. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st century. Expert Rev Anticancer Ther. 2009;9:1135–44.CrossRef Matushansky I, Charytonowicz E, Mills J, et al. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st century. Expert Rev Anticancer Ther. 2009;9:1135–44.CrossRef
15.
Zurück zum Zitat Mandal S, Mandal AK. Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin’s lymphoma. Int J Clin Oncol. 2007;12:52–5.CrossRef Mandal S, Mandal AK. Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin’s lymphoma. Int J Clin Oncol. 2007;12:52–5.CrossRef
16.
Zurück zum Zitat Kocer B, Gulbahar G, Erdogan B, et al. A case of radiation-induced sternal malignant fibrous histiocytoma treated with neoadjuvant chemotherapy and surgical resection. World J Surg Oncol. 2008;6:138.d.CrossRef Kocer B, Gulbahar G, Erdogan B, et al. A case of radiation-induced sternal malignant fibrous histiocytoma treated with neoadjuvant chemotherapy and surgical resection. World J Surg Oncol. 2008;6:138.d.CrossRef
17.
Zurück zum Zitat Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called “MFH”) in adults. J Surg Oncol. 2008;97:330–9.CrossRef Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called “MFH”) in adults. J Surg Oncol. 2008;97:330–9.CrossRef
18.
Zurück zum Zitat Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol. 2016;17:966–75.CrossRef Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol. 2016;17:966–75.CrossRef
19.
Zurück zum Zitat Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001;19:1238–47.CrossRef Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001;19:1238–47.CrossRef
20.
Zurück zum Zitat D. Crowther. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. The Lancet. 1997; 350:1647–54. D. Crowther. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. The Lancet. 1997; 350:1647–54.
21.
Zurück zum Zitat Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–81.CrossRef Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–81.CrossRef
22.
Zurück zum Zitat Gronchi A, Stacchiotti S, Verderio P, et al. Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. Ann Oncol. 2016;27:2283–8.CrossRef Gronchi A, Stacchiotti S, Verderio P, et al. Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. Ann Oncol. 2016;27:2283–8.CrossRef
23.
Zurück zum Zitat Tanaka K, Mizusawa J, Naka N, et al. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304. BMC Cancer. 2019;19:890.CrossRef Tanaka K, Mizusawa J, Naka N, et al. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304. BMC Cancer. 2019;19:890.CrossRef
24.
Zurück zum Zitat Tawbi HA, Burgess M, Bolejack V, et al. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017;18:1493–501.CrossRef Tawbi HA, Burgess M, Bolejack V, et al. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017;18:1493–501.CrossRef
Metadaten
Titel
Surgical resection of undifferentiated pleomorphic sarcoma (UPS) with jejunal perforation, a suspected case of metastasis of lung cancer
verfasst von
Ryotaro Eto
Isamu Hoshino
Nobuhiro Takiguchi
Toru Tonooka
Hisashi Gunji
Naoki Kuwayama
Itaru Sonoda
Makiko Itami
Masayuki Otsuka
Yoshihiro Nabeya
Publikationsdatum
21.07.2021
Verlag
Springer Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 5/2021
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01483-7

Weitere Artikel der Ausgabe 5/2021

Clinical Journal of Gastroenterology 5/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.